130 related articles for article (PubMed ID: 12027550)
1. IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma.
Lucas ML; Heller L; Coppola D; Heller R
Mol Ther; 2002 Jun; 5(6):668-75. PubMed ID: 12027550
[TBL] [Abstract][Full Text] [Related]
2. The effectiveness of calcium electroporation combined with gene electrotransfer of a plasmid encoding IL-12 is tumor type-dependent.
Lisec B; Markelc B; Ursic Valentinuzzi K; Sersa G; Cemazar M
Front Immunol; 2023; 14():1189960. PubMed ID: 37304301
[TBL] [Abstract][Full Text] [Related]
3. Stress hormones promote growth of B16-F10 melanoma metastases: an interleukin 6- and glutathione-dependent mechanism.
Valles SL; Benlloch M; Rodriguez ML; Mena S; Pellicer JA; Asensi M; Obrador E; Estrela JM
J Transl Med; 2013 Mar; 11():72. PubMed ID: 23517603
[TBL] [Abstract][Full Text] [Related]
4. Bacillus Calmette-Guérin immunotherapy induces an efficient antitumor response to control murine melanoma depending on MyD88 signaling.
Borges VM; Marinho FV; Caldeira CVA; de Queiroz NMGP; Oliveira SC
Front Immunol; 2024; 15():1380069. PubMed ID: 38835781
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral electroporation of IL-12 cDNA eradicates established melanomas by Trp2(180-188)-specific CD8+ CTLs in a perforin/granzyme-mediated and IFN-γ-dependent manner: application of Trp2(180-188) peptides.
Sin JI; Park JB; Lee IH; Park D; Choi YS; Choe J; Celis E
Cancer Immunol Immunother; 2012 Oct; 61(10):1671-82. PubMed ID: 22382361
[TBL] [Abstract][Full Text] [Related]
6. Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene elicits a specific T cell-dependent immune response.
Wack C; Kirst A; Becker JC; Lutz WK; Bröcker EB; Fischer WH
Cancer Immunol Immunother; 2002 Oct; 51(8):431-9. PubMed ID: 12202904
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory Function of Pien Tze Huang in T Cell-Mediated Anti-tumor Activity against B16-F10, MC38 and Hep1-6 Tumor Models.
Fu YB; Liu CF; Wang JJ; Ji XL; Tang RH; Liao KY; Chen LY; Hong YZ; Fan BB; Wang SC; Liu WH
Chin J Integr Med; 2024 Apr; 30(4):348-358. PubMed ID: 38212499
[TBL] [Abstract][Full Text] [Related]
8. Tumor specific phage particles promote tumor regression in a mouse melanoma model.
Eriksson F; Culp WD; Massey R; Egevad L; Garland D; Persson MA; Pisa P
Cancer Immunol Immunother; 2007 May; 56(5):677-87. PubMed ID: 16967280
[TBL] [Abstract][Full Text] [Related]
9. Single injection of IL-12 coacervate as an effective therapy against B16-F10 melanoma in mice.
Hwang MP; Fecek RJ; Qin T; Storkus WJ; Wang Y
J Control Release; 2020 Feb; 318():270-278. PubMed ID: 31866503
[TBL] [Abstract][Full Text] [Related]
10. Natural Products Induce Different Anti-Tumor Immune Responses in Murine Models of 4T1 Mammary Carcinoma and B16-F10 Melanoma.
Lasso P; Rojas L; Arévalo C; Urueña C; Murillo N; Fiorentino S
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069022
[TBL] [Abstract][Full Text] [Related]
11. Comparative delineation of T cell clonotypes in coexisting syngeneic B16 melanoma.
Moerch U; Schrama D; Guldberg P; Seremet T; Zeuthen J; Becker JC; thor Straten P
Cancer Immunol Immunother; 2000 Oct; 49(8):426-32. PubMed ID: 11043849
[TBL] [Abstract][Full Text] [Related]
12. p62-DNA-encoding plasmid reverts tumor grade, changes tumor stroma, and enhances anticancer immunity.
Venanzi FM; Gabai V; Mariotti F; Magi GE; Vullo C; Sufianov AA; Kolesnikov SI; Shneider A
Aging (Albany NY); 2019 Nov; 11(22):10711-10722. PubMed ID: 31754084
[TBL] [Abstract][Full Text] [Related]
13. Enhanced in vivo sensitivity to interferon with in vitro resistant B16 tumor cells in mice.
Fleischmann CM; Stanton GJ; Fleischmann WR
Cancer Immunol Immunother; 1994 Sep; 39(3):148-54. PubMed ID: 7923244
[TBL] [Abstract][Full Text] [Related]
14. Mouse Melanoma Model in Tumor Vaccines and Immunotherapy Research.
De Robertis M; Lampreht Tratar U; Signori E; Komel T; Čemažar M
Methods Mol Biol; 2024; 2773():157-163. PubMed ID: 38236544
[TBL] [Abstract][Full Text] [Related]
15. Laser-induced vapor nanobubbles for B16-F10 melanoma cell killing and intracellular delivery of chemotherapeutics.
Ramon J; Engelen Y; De Keersmaecker H; Goemaere I; Punj D; Mejía Morales J; Bonte C; Berx G; Hoste E; Stremersch S; Lentacker I; De Smedt SC; Raemdonck K; Braeckmans K
J Control Release; 2024 Jan; 365():1019-1036. PubMed ID: 38065413
[TBL] [Abstract][Full Text] [Related]
16. Combination of vesicular stomatitis virus matrix protein gene therapy with low-dose cisplatin improves therapeutic efficacy against murine melonoma.
Luo S; Chen P; Luo ZC; Zhang P; Sun P; Shi W; Li ZY; Zhang XL; Wang LQ; Chen X; Wei YQ; Wen YJ
Cancer Sci; 2010 May; 101(5):1219-25. PubMed ID: 20331624
[TBL] [Abstract][Full Text] [Related]
17. Characterization of abscopal effects of intratumoral electroporation-mediated IL-12 gene therapy.
Mukhopadhyay A; Wright J; Shirley S; Canton DA; Burkart C; Connolly RJ; Campbell JS; Pierce RH
Gene Ther; 2019 Feb; 26(1-2):1-15. PubMed ID: 30323352
[TBL] [Abstract][Full Text] [Related]
18. Tumor regression following intravenous administration of a tumor-targeted p73 gene delivery system.
Lemarié F; Croft DR; Tate RJ; Ryan KM; Dufès C
Biomaterials; 2012 Mar; 33(9):2701-9. PubMed ID: 22200536
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic combination silencing VEGF and SOX10 increases the antiangiogenic effect in the mouse melanoma model B16-F10 -
Bogusławska-Duch J; Ducher-Hanaka M; Zajkowska A; Czajka M; Małecki M
Postepy Dermatol Alergol; 2021 Oct; 38(5):887-898. PubMed ID: 34849139
[TBL] [Abstract][Full Text] [Related]
20. Intricacies for posttranslational tumor-targeted cytokine gene therapy.
Cutrera J; Dibra D; Satelli A; Xia X; Li S
Mediators Inflamm; 2013; 2013():378971. PubMed ID: 24369443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
